BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 16570072)

  • 1. Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome.
    Redon R; Baujat G; Sanlaville D; Le Merrer M; Vekemans M; Munnich A; Carter NP; Cormier-Daire V; Colleaux L
    Eur J Hum Genet; 2006 Jun; 14(6):759-67. PubMed ID: 16570072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
    Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
    J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterisation of patients with subtelomeric 22q abnormalities using chromosome specific array-based comparative genomic hybridisation.
    Koolen DA; Reardon W; Rosser EM; Lacombe D; Hurst JA; Law CJ; Bongers EM; van Ravenswaaij-Arts CM; Leisink MA; van Kessel AG; Veltman JA; de Vries BB
    Eur J Hum Genet; 2005 Sep; 13(9):1019-24. PubMed ID: 15986041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1.
    Rajcan-Separovic E; Harvard C; Liu X; McGillivray B; Hall JG; Qiao Y; Hurlburt J; Hildebrand J; Mickelson EC; Holden JJ; Lewis ME
    J Med Genet; 2007 Apr; 44(4):269-76. PubMed ID: 16963482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further delineation of 9q22 deletion syndrome associated with basal cell nevus (Gorlin) syndrome: report of two cases and review of the literature.
    Yamamoto K; Yoshihashi H; Furuya N; Adachi M; Ito S; Tanaka Y; Masuno M; Chiyo H; Kurosawa K
    Congenit Anom (Kyoto); 2009 Mar; 49(1):8-14. PubMed ID: 19243411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of an interstitial deletion 6q13-q14.1 in a female with mild mental retardation, language delay and minor dysmorphisms.
    Lespinasse J; Gimelli S; Béna F; Antonarakis SE; Ansermet F; Paoloni-Giacobino A
    Eur J Med Genet; 2009; 52(1):49-52. PubMed ID: 18992376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in NSD1 are responsible for Sotos syndrome, but are not a frequent finding in other overgrowth phenotypes.
    Türkmen S; Gillessen-Kaesbach G; Meinecke P; Albrecht B; Neumann LM; Hesse V; Palanduz S; Balg S; Majewski F; Fuchs S; Zschieschang P; Greiwe M; Mennicke K; Kreuz FR; Dehmel HJ; Rodeck B; Kunze J; Tinschert S; Mundlos S; Horn D
    Eur J Hum Genet; 2003 Nov; 11(11):858-65. PubMed ID: 14571271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA microarray analysis identifies candidate regions and genes in unexplained mental retardation.
    Engels H; Brockschmidt A; Hoischen A; Landwehr C; Bosse K; Walldorf C; Toedt G; Radlwimmer B; Propping P; Lichter P; Weber RG
    Neurology; 2007 Mar; 68(10):743-50. PubMed ID: 17339581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial 6q deletion: clinical and array CGH characterisation of a new patient.
    Le Caignec C; Swillen A; Van Asche E; Fryns JP; Vermeesch JR
    Eur J Med Genet; 2005; 48(3):339-45. PubMed ID: 16179229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-phenotype correlations to aid in the prognosis of individuals with uncommon 20q13.33 subtelomere deletions: a collaborative study on behalf of the 'association des Cytogénéticiens de langue Française'.
    Béri-Deixheimer M; Gregoire MJ; Toutain A; Brochet K; Briault S; Schaff JL; Leheup B; Jonveaux P
    Eur J Hum Genet; 2007 Apr; 15(4):446-52. PubMed ID: 17290276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel deletions of 15q11q13 in Angelman syndrome by array-CGH: molecular characterization and genotype-phenotype correlations.
    Sahoo T; Bacino CA; German JR; Shaw CA; Bird LM; Kimonis V; Anselm I; Waisbren S; Beaudet AL; Peters SU
    Eur J Hum Genet; 2007 Sep; 15(9):943-9. PubMed ID: 17522620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards mapping phenotypical traits in 18p- syndrome by array-based comparative genomic hybridisation and fluorescent in situ hybridisation.
    Brenk CH; Prott EC; Trost D; Hoischen A; Walldorf C; Radlwimmer B; Wieczorek D; Propping P; Gillessen-Kaesbach G; Weber RG; Engels H
    Eur J Hum Genet; 2007 Jan; 15(1):35-44. PubMed ID: 17024214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A familial case of overgrowth syndrome caused by a 9q22.3 microdeletion in a mother and daughter.
    Yamada H; Shimura M; Takahashi H; Nara S; Morishima Y; Go S; Miyashita T; Numabe H; Kawashima H
    Eur J Med Genet; 2020 May; 63(5):103872. PubMed ID: 32028043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proximal interstitial 1p36 deletion syndrome: the most proximal 3.5-Mb microdeletion identified on a dysmorphic and mentally retarded patient with inv(3)(p14.1q26.2).
    Shimojima K; Páez MT; Kurosawa K; Yamamoto T
    Brain Dev; 2009 Sep; 31(8):629-33. PubMed ID: 18835671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Untreated growth hormone deficiency with extremely short stature, bone dysplasia, cleft lip--palate and severe mental retardation in a 26-year-old man with a de novo unbalanced translocation t(1;12)(q24;q24).
    Callier P; Faivre L; Marle N; Thauvin-Robinet C; Mosca AL; Masurel-Paulet A; Borgnon J; Falcon-Eicher S; Danino A; Malka G; Le Merrer M; Huet F; Mugneret F
    Eur J Med Genet; 2007; 50(6):455-64. PubMed ID: 17720646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation.
    Malan V; Raoul O; Firth HV; Royer G; Turleau C; Bernheim A; Willatt L; Munnich A; Vekemans M; Lyonnet S; Cormier-Daire V; Colleaux L
    J Med Genet; 2009 Sep; 46(9):635-40. PubMed ID: 19126570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The 8q22.1 microdeletion syndrome or Nablus mask-like facial syndrome: report on two patients and review of the literature.
    Raas-Rothschild A; Dijkhuizen T; Sikkema-Raddatz B; Werner M; Dagan J; Abeliovich D; Lerer I
    Eur J Med Genet; 2009; 52(2-3):140-4. PubMed ID: 19328248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new syndrome of proximal deletion of the long arm of chromosome 1: 1q21-23 leads to 1q25.
    Taysi K; Sekhon GS; Hillman RE
    Am J Med Genet; 1982 Dec; 13(4):423-30. PubMed ID: 7158642
    [No Abstract]   [Full Text] [Related]  

  • 19. Twelve new patients with 13q deletion syndrome: genotype-phenotype analyses in progress.
    Quélin C; Bendavid C; Dubourg C; de la Rochebrochard C; Lucas J; Henry C; Jaillard S; Loget P; Loeuillet L; Lacombe D; Rival JM; David V; Odent S; Pasquier L
    Eur J Med Genet; 2009; 52(1):41-6. PubMed ID: 19022413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion 2q36.2q36.3 with multiple renal cysts and severe mental retardation.
    Doco-Fenzy M; Landais E; Andrieux J; Schneider A; Delemer B; Sulmont V; Melin JP; Ploton D; Thevenard J; Monboisse JC; Belouadah M; Lefebvre F; Durlach A; Goossens M; Albuisson J; Motte J; Gaillard D
    Eur J Med Genet; 2008; 51(6):598-607. PubMed ID: 18822396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.